NeuralPort Secures New Funding from Mitsubishi UFJ Morgan Stanley Securities
NeuralPort, a Hyogo-based health-tech startup specializing in brain performance, has successfully closed a Seed Extension funding round. The latest infusion of capital brings the company’s cumulative funding to date to 170 million yen.
The round was comprised of a third-party allotment of shares to Mitsubishi UFJ Morgan Stanley Securities and several angel investors, complemented by debt financing from the Japan Finance Corporation.
Led by Representative Director Anna Shimafuji, NeuralPort operates under the mission to "Update the Brain OS." The company targets high-performance individuals, particularly professional athletes, through the development of proprietary neuro-assessment tools. Its flagship products include "ZEN EYE Pro," a VR-based system designed to measure mental fatigue, and "ZONE-Z," a training pod engineered to scientifically replicate the "flow state" or "zone."
The startup’s research and development are rooted in a cross-disciplinary approach, integrating experimental psychology, neuroscience, eye-tracking technology, and robotics.
Headquartered in Ashiya City, NeuralPort was established in September 2020. This latest capital injection is expected to accelerate the company’s R&D initiatives and expand the deployment of its brain fatigue measurement services, which have already begun seeing adoption within professional sports sectors, including a recently announced partnership with the Honda baseball team for the 2026 season.
